Gal Cafri

1.5k citations
17 papers · 819 · 1 hit paper · h-index 12

Impact in

  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
  • Oncology top 5%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Immunotherapy and Immune Responses 14
    • T-cell and B-cell Immunology 6
    • Immune Cell Function and Interaction 4
    • Immune Response and Inflammation 2
    • CAR-T cell therapy research 9
    • Cancer Immunotherapy and Biomarkers 7

Gal Cafri

17 papers receiving 798 citations

Gal Cafri's Hit Papers

mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer 2020 · 334 citations
3340+2+4Years since publication100200300

Peers

Gal Cafri
Comparison fields: 5 of 52
  • Immunology 532
  • Oncology 490
  • Molecular Biology 330
  • Radiology, Nuclear Medicine and Imaging 74
  • Genetics 90
Replace Marten Visser with:
Marten Visser Netherlands
Xuexiang Du United States
William R. Gwin United States
Anthony Miliotto United States
C.J.M. Melief Netherlands
Dries Renmans Belgium
Lazar Vujanović United States
Katrijn Broos Belgium
Erika J. Crosby United States
Emi A. Lutz United States
Gal Cafri relative to Marten Visser Netherlands Marten Visser's profile →
Citations per field
00.5×1.5×2.1×
Marten Visser · 1×
Citations per year

Countries citing papers authored by Gal Cafri

Since Specialization
Citations

This map shows the geographic impact of Gal Cafri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gal Cafri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gal Cafri more than expected).

Fields of papers citing papers by Gal Cafri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gal Cafri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gal Cafri. The network helps show where Gal Cafri may publish in the future.

Co-authors

The 25 scholars most cited alongside Gal Cafri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gal Cafri Line = papers co-authored together Gal Cafri links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
Hit paper breakdown →
2020334
2 2018158
3 2019115
4 202131
5 200530
6 201424
7 201918
8 202117
9 201516
10 201816
11 201515
12 201111
13 201610
14 20139
15 20187
16 20227
17 20131

About Gal Cafri

Gal Cafri is a scholar working on Immunology, Oncology, Molecular Biology, Infectious Diseases and Organic Chemistry, having authored 17 papers that have together received 819 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (14 papers), CAR-T cell therapy research (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), T-cell and B-cell Immunology (6 papers), vaccines and immunoinformatics approaches (4 papers), Immune Cell Function and Interaction (4 papers), Immune Response and Inflammation (2 papers) and Heat shock proteins research (1 paper). The work is most often cited by research in Immunology (532 citations), Oncology (490 citations), Molecular Biology (330 citations), Radiology, Nuclear Medicine and Imaging (74 citations) and Genetics (90 citations). Gal Cafri has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Jared J. Gartner, Steven A. Rosenberg, Paul F. Robbins, Rami Yossef, Todd D. Prickett, Maria R. Parkhurst, Mohammad Jafferji, Anna Pasetto, Biman C. Paria and Noam Levin. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology, Clinical Cancer Research, Nature Communications and Clinical & Experimental Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact